The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

The Rio-based network of independent pharmacies blames drug industry intermediaries known as pharmacy benefit managers.

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

10. An analysis of a generic drug used to treat bacterial infections showed that an Optum-affiliated pharmacy received a payment eight times higher than that of the lowest-paid independent pharmacy on ...

Analyst Allen Lutz of Bank of America Securities reiterated a Sell rating on GoodRx Holdings (GDRX – Research Report), reducing the price ...

The plaintiff pharmacies alleged that GoodRx, a prescription discount card aggregator, and four of the largest pharmacy ...

There is a tendency to overlook the multiple factors and stakeholders that contributed to the Rx opioid crisis. This includes ...

Despite the current revenue model being largely dependent on generics and arrangements with pharmacy benefit managers (PBMs), which present vulnerabilities due to external factors, Rhyee acknowledges ...

Welcome to the GoodRx third-quarter 2024 earnings call. As a reminder, today's conference call is being recorded. I would now ...

A handful of current Democratic House members are among the incoming senators who will face a new GOP majority in the Senate.

CerpassRx, an independent pharmacy benefit manager, is teaming up with Waltz Health to launch a new AI-powered tool that aims ...

3430), provide badly needed reforms to make sure, first, that patients receive medication discounts they rightfully deserve; and second, to keep PBMs from profiting off the backs of patients. I urge ...